Doctor and Patient.

How to initiate treatment with ZILBRYSQ

Doctor and Patient.

Get your patients started on ZILBRYSQ and enrolled in ONWARD® with these 3 steps

 

STEP 1

Enroll in the ZILBRYSQ REMS (Risk Evaluation and Mitigation Strategy)

Before prescribing ZILBRYSQ to patients, healthcare providers must become certified in the ZILBRYSQ REMS, which is intended to mitigate the risk of serious meningococcal infections.

Check the vaccination schedule to determine if it is necessary to complete or update the meningococcal vaccination series for your patient.

Vaccinate patients against meningococcal infection according to the full ZILBRYSQ Prescribing Information two weeks prior to the first dose of ZILBRYSQ.1

To learn more or become certified, please visit ZILBRYSQREMS.com or call 1‑877‑414‑8353.

STEP 2

Consider enrolling your patients in ONWARD

ONWARD®.

To get an eligible patient started on ZILBRYSQ and enrolled in ONWARD, complete the ONWARD Start Form (either electronically or by filling out the PDF and faxing it to ONWARD). ONWARD can collect the patient’s HIPAA authorization electronically, if needed. Visit ZILBRYSQHCP.com/initiate to download the form.

If you have questions about enrolling your patients in ONWARD, visit ucbONWARD.com/hcp/ZILBRYSQ or contact your Rare Reimbursement Executive (RRE).

ONWARD®.

STEP 3

Your patients are ready with ONWARD

ONWARD Care Coordinators* work with patients throughout their ZILBRYSQ treatment journey by providing education and personalized support, from initiation through continuation of treatment, as prescribed, with services such as:

  • A 1-business-day turnaround time from intake to prescription triage with a completed Start Form
  • A dedicated Care Coordinator to help eligible patients start and stay on their prescribed treatment, as appropriate. The Care Coordinator can address patients’ questions about self-injection and affordability.
  • A Demo Device and refresher injection coaching with a Care Coordinator through video chat to help them prepare to self-administer ZILBRYSQ. Patients can find the full list of steps in the Instructions for Use

ONWARD does not provide medical advice and does not replace the care of the healthcare provider. Care Coordinators will refer patients to their healthcare provider for any treatment-related questions.

ONWARD is provided as a service of UCB and is intended to support the appropriate use of UCB medicines. ONWARD may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.

Reference:

  1. ZILBRYSQ [Prescribing Information]. Smyrna, GA: UCB, Inc.